Denatonium Completed Phase 2 Trials for Obesity Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT05121441
Study to Evaluate ARD-101 in Adults With Obesity